Provided by Tiger Trade Technology Pte. Ltd.

Merus NV

90.00
0.0000
Volume:- -
Turnover:252.73M
Market Cap:6.83B
PE:-16.79
High:90.00
Open:90.00
Low:90.00
Close:90.00
52wk High:97.14
52wk Low:33.19
Shares:75.85M
Float Shares:65.61M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.3613
EPS(LYR):-3.3529
ROE:-51.57%
ROA:-26.53%
PB:8.81
PE(LYR):-26.84

Loading ...

Fourteen option delistings on January 21st

TIPRANKS
·
Jan 21

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:00 AM

Reuters
·
Dec 30, 2025

NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM

Reuters
·
Dec 30, 2025

Genmab scraps development of experimental cancer therapy

Reuters
·
Dec 29, 2025

Genmab A/S Reports Acquisition of Merus NV Common Shares

Reuters
·
Dec 23, 2025

Merus NV Files Initial Beneficial Ownership Statement Naming Genmab A/S as 10% Owner

Reuters
·
Dec 19, 2025

Merus (MRUS): Reassessing Valuation After a 120% Year-to-Date Rally and Strong Multi-Year Returns

Simply Wall St.
·
Dec 17, 2025

Genmab: Completion Of Tender Offer For Outstanding Common Shares Of Merus N.V.

Reuters
·
Dec 12, 2025

Genmab Completes Tender Offer for Merus Shares

Reuters
·
Dec 12, 2025

Merus NV Held Extraordinary General Meeting of Shareholders

Reuters
·
Dec 10, 2025

Genmab Closes $2.5 Billion Notes Offering to Fund Merus Acquisition

Reuters
·
Dec 04, 2025

Merus (MRUS): Evaluating the Biotech’s Valuation After a 127% Year-to-Date Surge

Simply Wall St.
·
Nov 26, 2025

Genmab Prices $2.5 Billion in Notes to Fund Acquisition of Merus

Reuters
·
Nov 19, 2025

Halozyme Signs Global License Agreement With Merus for Subcutaneous Petosemtamab

Reuters
·
Nov 17, 2025

Did Rising Nine-Month Losses and Modest Revenue Growth Just Shift Merus' (MRUS) Investment Narrative?

Simply Wall St.
·
Nov 14, 2025

Genmab Announces Proposed Private Offerings

Reuters
·
Nov 10, 2025

Genmab Launches $4.5 Billion Financing to Acquire Merus

Reuters
·
Nov 10, 2025

Assessing Merus (MRUS) Valuation After Its Recent Surge in Share Price

Simply Wall St.
·
Nov 08, 2025

Genmab reports 21% revenue growth and 52% operating profit increase for first nine months of 2025

Reuters
·
Nov 07, 2025

Genmab to Acquire Merus for $8 Billion in All-Cash Deal

Reuters
·
Nov 07, 2025